Chemical Structure (Ponesimod 01)
Ponvory Kit
Product Images NDC 50458-707
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ponvory (NDC 50458-707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Janssen Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (20 mg Tablet Bottle Carton)
Each tablet of & Ponvory® (ponesimod) contains 20 mg of the active ingredient made in Austria. This package contains 30 film-coated tablets and is child-resistant. The tablets should be stored in the original package at a temperature between 20°C and 25°C (68°F to 77°F) and should not be exposed to moisture. Excursions between 15°C to 30°C (59°F to 86°F) are permitted but should be avoided. Rxonly. Includes enclosed Medication Guide.*
Principal Display Panel (Kit Carton)
The text contains information about a medication called Ponvory, which comes in a 14-day starter pack with tablets of different dosages (2mg, 3mg, 4mg, 6mg, 7mg, 8mg, 9mg, and 10mg). The medication guide should be given to each patient, and the tablets are film-coated. The rest of the text appears to be distorted or gibberish and is not readable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
